Ashfield Engage has agreed a deal to incorporate Popit’s digital tools in its patient support programmes, with the aim of improving adherence to treatments.
With up to a quarter of US children and adolescents affected by a chronic condition, Sinead Ni Mhurchadha and Anna O’Sullivan stress the importance of understanding their needs and developing t
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.